Echinomycin
- PMID: 1299809
Echinomycin
Abstract
The story of echinomycin is of an antibiotic whose anti-cancer activity was rediscovered thanks to scientific investigation of its mode of action at the molecular level. It was the first DNA bis-intercalator identified (in 1974). Molecular models for echinomycin and its congeners are now well-founded on crystallographic data. These are beginning to throw light on significant variations in conformation which affect the ability of the antibiotics to recognise specific nucleotide sequences in DNA. Kinetic and other physical experiments have revealed much about the stability and selectivity of antibiotic-DNA complexes: stacking forces are important, as are hydrogen bonding interactions. Echinomycin preferentially recognises sites in DNA containing the CpG step, but other sites of lower occupancy exist and the antibiotic can migrate between them. Currently a good deal of attention is being paid to the suggestion that echinomycin might change Watson-Crick base pairs to a Hoogsteen form.
Similar articles
-
Recognition elements that determine affinity and sequence-specific binding to DNA of 2QN, a biosynthetic bis-quinoline analogue of echinomycin.Anticancer Drug Des. 1999 Jun;14(3):291-303. Anticancer Drug Des. 1999. PMID: 10500504
-
Structures of complexes between echinomycin and duplex DNA.Acta Crystallogr D Biol Crystallogr. 2005 Apr;61(Pt 4):442-8. doi: 10.1107/S090744490500137X. Epub 2005 Mar 24. Acta Crystallogr D Biol Crystallogr. 2005. PMID: 15805599
-
NMR investigation of Hoogsteen base pairing in quinoxaline antibiotic--DNA complexes: comparison of 2:1 echinomycin, triostin A and [N-MeCys3,N-MeCys7] TANDEM complexes with DNA oligonucleotides.Nucleic Acids Res. 1994 Dec 11;22(24):5484-91. doi: 10.1093/nar/22.24.5484. Nucleic Acids Res. 1994. PMID: 7816641 Free PMC article.
-
DNA recognition by intercalators and hybrid molecules.J Mol Recognit. 1994 Jun;7(2):109-22. doi: 10.1002/jmr.300070208. J Mol Recognit. 1994. PMID: 7826671 Review.
-
Diversification of echinomycin molecular structure by way of chemoenzymatic synthesis and heterologous expression of the engineered echinomycin biosynthetic pathway.Curr Opin Chem Biol. 2009 Apr;13(2):189-96. doi: 10.1016/j.cbpa.2009.02.012. Epub 2009 Mar 9. Curr Opin Chem Biol. 2009. PMID: 19278894 Review.
Cited by
-
The UvrA-like protein Ecm16 requires ATPase activity to render resistance against echinomycin.Mol Microbiol. 2022 Jun;117(6):1434-1446. doi: 10.1111/mmi.14918. Epub 2022 May 30. Mol Microbiol. 2022. PMID: 35534931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous